AstraZeneca Australia
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. They are also selectively active in the areas of autoimmunity, neuroscience and infection. They build their own capabilities by collaborating with world-renowned scientists and academic institutions, and partner with like-minded, science-led companies. AstraZeneca Australia, have been working to deliver the best value to patients for more than 60 years, and they push the boundaries of science to deliver life-changing medicines.


Modules
EA:
1
MO:
0
RP:
0
Total:
1
On-demand MEDTalks: COPD and CV risk - a mortal tale

Modules
EA:
1.5
MO:
0
RP:
0
Total:
1.5
On-demand webinar: COPD and cardiovascular risk: The deadly duo

Audits
EA:
1.5
MO:
4
RP:
1
Total:
6.5
Clinical audit: Managing the deadly duo of COPD and cardiovascular risk